Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Zanganeh Mahkam

Over the trailing 90 days, Zanganeh Mahkam (Director at Summit Therapeutics Inc.) bought $51.4M of stock across 2 companies, per 4 SEC Form 4 transactions.

Role: Director
Companies: SMMT PLSE
Window: Trailing 90 days · 4 transactions · CIK 1507650
Net activity: +$51.4M ($51.4M bought · $0 sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
SMMT	Summit Therapeutics Inc.	2	$51.4M	—	$51.4M
PLSE	PULSE BIOSCIENCES, INC.	2	—	—	$0

Transactions (4)

Date	Symbol	Type	Shares	Value	Description
2026-06-12	SMMT	Buy	3.8M	$50.0M	Open market or private purchase
2026-06-11	PLSE	Buy	14.5K	$0	Grant, award or other acquisition
2026-06-11	PLSE	Buy	30.0K	$0	Grant, award or other acquisition
2026-06-04	SMMT	Buy	100.0K	$1.5M	Open market or private purchase

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Zanganeh's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free